FY20 tbdrp support services
Ended Awarded Last action
- Contract number
- W81XWH20F0202
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $300,438
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 84% obligated
- $357,255.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$47,633 | |
| Supplemental Agreement for work within scope | $12,369 | |
| Funding Only Action | $54,605 | |
| Exercise an Option | $59,365 | |
| Exercise an Option | $113,922 | |
| Funding Only Action | -$4,500 | |
| Other Administrative Action | $0 | |
| Original award | $112,310 |
About this award
Leidos, Inc., through its Leidos Services Operating Segment (doing business as SAIC), received a delivery order contract valued at $357,255.90 from the Defense Health Agency for Fiscal Year 2020 Tick-Borne Disease Research Program support services. The contract, awarded on June 10, 2020, with an ultimate completion date of June 9, 2023, operates under a Cost Plus Fixed Fee pricing structure with no small business set-aside designation. Work will be performed in Herndon, Virginia. This delivery order supports the Defense Health Agency's research initiatives focused on tick-borne diseases, a priority area within the military health system given the prevalence of such conditions among service members.
As a leading global technology and engineering solutions provider, Leidos demonstrates extensive capabilities in federal medical research program support across multiple agencies and disease areas. The company's track record includes significant contracts with the Defense Health Agency, National Cancer Institute, and National Institute of Allergy and Infectious Diseases, positioning it well to deliver comprehensive research support services. Leidos Holdings, Inc., the parent company, maintains a substantial federal contract portfolio spanning defense, intelligence, health, and civilian sectors, with multiple large-scale indefinite delivery contracts that underscore its established position as a versatile government contractor capable of executing complex research and technical missions.
Quick answers
Who was awarded contract W81XWH20F0202?
W81XWH20F0202 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on June 10, 2020.
How much is contract W81XWH20F0202 worth?
The government has obligated $300,438 on W81XWH20F0202. Its current value, with exercised options, is $357,256.
Is contract W81XWH20F0202 an order under another contract?
Yes. W81XWH20F0202 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH20F0202 competed?
The extent of competition for W81XWH20F0202 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award